Reports - Personalized Medicine Market
HealthcarePersonalized Medicine Market
Personalized Medicine Market Trends, Growth & Innovations (2025–2035) by Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness) by Application (Oncology, Neurology, Cardiology, Antiviral, Psychiatry, Immunology, Others) by End Users (Hospitals And Clinical Care, Diagnostic Companies And Testing Facilities, Academic Research Institutes And Research Laboratories, Contract Research Organizations, Bio And Health Informatics Companies, Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Personalized Medicine Market - Segment Analysis
1. Overview
2. Global Personalized Medicine Market, 2021 - 2035 (USD Million)
3. Global Personalized Medicine Market - by Product
3.1. By Personalized Medicine Diagnostics
3.2. By Personalized Medicine Therapeutics
3.3. By Personalized Medical Care
3.4. By Personalized Nutrition & Wellness
4. Global Personalized Medicine Market - by Application
4.1. By Oncology
4.2. By Neurology
4.3. By Cardiology
4.4. By Antiviral
4.5. By Psychiatry
4.6. By Immunology
4.7. By Other Applications
5. Global Personalized Medicine Market - by End Users
5.1. By Hospitals & Clinical Care
5.2. By Diagnostic Companies And Testing Facilities
5.3. By Academic Research Institutes And Research Laboratories
5.4. By Contract Research Organizations
5.5. By Bio and Health Informatics Companies
5.6. By Other End Users
6. Global Personalized Medicine Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Personalized Medicine Market - Segment Analysis
1. Overview
2. North America Personalized Medicine Market, 2021 - 2035 (USD Million)
3. North America Personalized Medicine Market - by Product
3.1. By Personalized Medicine Diagnostics
3.2. By Personalized Medicine Therapeutics
3.3. By Personalized Medical Care
3.4. By Personalized Nutrition & Wellness
4. North America Personalized Medicine Market - by Application
4.1. By Oncology
4.2. By Neurology
4.3. By Cardiology
4.4. By Antiviral
4.5. By Psychiatry
4.6. By Immunology
4.7. By Other Applications
5. North America Personalized Medicine Market - by End Users
5.1. By Hospitals & Clinical Care
5.2. By Diagnostic Companies And Testing Facilities
5.3. By Academic Research Institutes And Research Laboratories
5.4. By Contract Research Organizations
5.5. By Bio and Health Informatics Companies
5.6. By Other End Users
Chapter 5 Europe Personalized Medicine Market - Segment Analysis
1. Overview
2. Europe Personalized Medicine Market, 2021 - 2035 (USD Million)
3. Europe Personalized Medicine Market - by Product
3.1. By Personalized Medicine Diagnostics
3.2. By Personalized Medicine Therapeutics
3.3. By Personalized Medical Care
3.4. By Personalized Nutrition & Wellness
4. Europe Personalized Medicine Market - by Application
4.1. By Oncology
4.2. By Neurology
4.3. By Cardiology
4.4. By Antiviral
4.5. By Psychiatry
4.6. By Immunology
4.7. By Other Applications
5. Europe Personalized Medicine Market - by End Users
5.1. By Hospitals & Clinical Care
5.2. By Diagnostic Companies And Testing Facilities
5.3. By Academic Research Institutes And Research Laboratories
5.4. By Contract Research Organizations
5.5. By Bio and Health Informatics Companies
5.6. By Other End Users
Chapter 6 Asia Pacific Personalized Medicine Market - Segment Analysis
1. Overview
2. Asia Pacific Personalized Medicine Market, 2021 - 2035 (USD Million)
3. Asia Pacific Personalized Medicine Market - by Product
3.1. By Personalized Medicine Diagnostics
3.2. By Personalized Medicine Therapeutics
3.3. By Personalized Medical Care
3.4. By Personalized Nutrition & Wellness
4. Asia Pacific Personalized Medicine Market - by Application
4.1. By Oncology
4.2. By Neurology
4.3. By Cardiology
4.4. By Antiviral
4.5. By Psychiatry
4.6. By Immunology
4.7. By Other Applications
5. Asia Pacific Personalized Medicine Market - by End Users
5.1. By Hospitals & Clinical Care
5.2. By Diagnostic Companies And Testing Facilities
5.3. By Academic Research Institutes And Research Laboratories
5.4. By Contract Research Organizations
5.5. By Bio and Health Informatics Companies
5.6. By Other End Users
Chapter 7 Latin America Personalized Medicine Market - Segment Analysis
1. Overview
2. Latin America Personalized Medicine Market, 2021 - 2035 (USD Million)
3. Latin America Personalized Medicine Market - by Product
3.1. By Personalized Medicine Diagnostics
3.2. By Personalized Medicine Therapeutics
3.3. By Personalized Medical Care
3.4. By Personalized Nutrition & Wellness
4. Latin America Personalized Medicine Market - by Application
4.1. By Oncology
4.2. By Neurology
4.3. By Cardiology
4.4. By Antiviral
4.5. By Psychiatry
4.6. By Immunology
4.7. By Other Applications
5. Latin America Personalized Medicine Market - by End Users
5.1. By Hospitals & Clinical Care
5.2. By Diagnostic Companies And Testing Facilities
5.3. By Academic Research Institutes And Research Laboratories
5.4. By Contract Research Organizations
5.5. By Bio and Health Informatics Companies
5.6. By Other End Users
Chapter 8 Middle East & Africa Personalized Medicine Market - Segment Analysis
1. Overview
2. Middle East & Africa Personalized Medicine Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Personalized Medicine Market - by Product
3.1. By Personalized Medicine Diagnostics
3.2. By Personalized Medicine Therapeutics
3.3. By Personalized Medical Care
3.4. By Personalized Nutrition & Wellness
4. Middle East & Africa Personalized Medicine Market - by Application
4.1. By Oncology
4.2. By Neurology
4.3. By Cardiology
4.4. By Antiviral
4.5. By Psychiatry
4.6. By Immunology
4.7. By Other Applications
5. Middle East & Africa Personalized Medicine Market - by End Users
5.1. By Hospitals & Clinical Care
5.2. By Diagnostic Companies And Testing Facilities
5.3. By Academic Research Institutes And Research Laboratories
5.4. By Contract Research Organizations
5.5. By Bio and Health Informatics Companies
5.6. By Other End Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Abbott Laboratories (U.S.)
2. Merck & Co. Inc. (U.S.)
3. Astrazeneca (UK)
4. Pfizer Inc. (U.S.)
5. Glaxosmithkline PLC (UK)
6. Novartis AG (Switzerland)
7. Amgen Inc. (U.S.)
8. Bayer AG (Germany)
9. Eli Lilly & Company (U.S.)
10. Illumina Inc. (U.S.)
11. Danaher Corporation (U.S.)
12. QIAGEN (Germany)
13. 23andMe Inc. (U.S.)
14. Roche (Switzerland)
15. Thermo Fisher Scientific (U.S.)
16. GE Healthcare (U.S.)
17. Precision Biologics (Canada)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By